BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12346928)

  • 21. [The vaccination coverage rate: why is it so low?].
    Wembonyama O
    Dev Sante; 1994; (112):23-6. PubMed ID: 12318877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Principles of tuberculosis control.
    Child Health Dialogue; 1996; Suppl():4-5. PubMed ID: 12292163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tuberculosis: vaccines in the pipeline.
    Ly LH; McMurray DN
    Expert Rev Vaccines; 2008 Jul; 7(5):635-50. PubMed ID: 18564018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Assessment of effectiveness of BCG vaccination against childhood tuberculosis].
    Takamatsu I; Kameda M; Inoue T; Toyoshima K
    Kekkaku; 1995 Sep; 70(9):561-6. PubMed ID: 8523863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCG vaccination and pediatric HIV infection--Rwanda, 1988-1990.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Dec; 40(48):833-6. PubMed ID: 1956369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of tuberculosis in children. Detection and chemotherapy of infectious cases of tuberculosis.
    Chaulet P; Ait Khaled N
    Child Trop; 1992; (196-197):60-9. PubMed ID: 12345142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted BCG vaccination against severe tuberculosis in low-prevalence settings: epidemiologic and economic assessment.
    Altes HK; Dijkstra F; Lugnèr A; Cobelens F; Wallinga J
    Epidemiology; 2009 Jul; 20(4):562-8. PubMed ID: 19295437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thiamphenicol in treatment of genital gonorrhoeae in Central African Republic.
    Widy-wirski ; Meheus A; Lala B; Piot P; D'costa J
    Afr J Sex Transmi Dis; 1984; 1(1):11-3. PubMed ID: 12340181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of the literature on the economics of vaccination against TB.
    Tu HA; Vu HD; Rozenbaum MH; Woerdenbag HJ; Postma MJ
    Expert Rev Vaccines; 2012 Mar; 11(3):303-17. PubMed ID: 22380823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human factors in the TB epidemic.
    Ruck N
    Afr Health; 1997 Nov; 20(1):23-4. PubMed ID: 12348377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bovine TB and the development of new vaccines.
    Hope JC; Villarreal-Ramos B
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):77-100. PubMed ID: 17764740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [BCG vaccination in the world].
    Toida I
    Kekkaku; 2000 Jan; 75(1):1-7. PubMed ID: 10689812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is intranasal vaccination a feasible solution for tuberculosis?
    Giri PK; Khuller GK
    Expert Rev Vaccines; 2008 Nov; 7(9):1341-56. PubMed ID: 18980538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guérin in Finland.
    Hersh AL; Tala-Heikkilä M; Tala E; Tosteson AN; Fordham von Reyn C
    Int J Tuberc Lung Dis; 2003 Jan; 7(1):22-9. PubMed ID: 12701831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination strategies to prevent tuberculosis in the new millennium: from BCG to new vaccine candidates.
    Franco-Paredes C; Rouphael N; del Rio C; Santos-Preciado JI
    Int J Infect Dis; 2006 Mar; 10(2):93-102. PubMed ID: 16377228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis.
    Xing Z; Charters TJ
    Expert Rev Vaccines; 2007 Aug; 6(4):539-46. PubMed ID: 17669008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuberculin survey among school-aged children in Ahvaz, Iran, 2006.
    Alavi SM; Sefidgaran GH
    Int J Infect Dis; 2008 Jul; 12(4):406-9. PubMed ID: 18248754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Results of the BCG vaccination in Hungary since 1929: evaluation of preventive and immunotherapeutic effectiveness].
    Lugosi L
    Orv Hetil; 1998 Jun; 139(26):1563-70. PubMed ID: 9676117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine researchers rise to the challenge of resurgent TB.
    Vaccine Immun News; 1996 Jun; (1):4-6. PubMed ID: 12179918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hib vaccine introduced in The Gambia.
    Wenger J
    Afr Health; 1997 Nov; 20(1):13, 15. PubMed ID: 12348371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.